The results of the COLARIS® test enable the development of a patient-specific medical management roadmap to significantly reduce the risk of cancer. COLARIS® will allow you to:
Target increased surveillance and other interventions only to individuals with a Lynch syndrome mutation—maximizing patient care and increasing clinical efficiency
Significantly improve outcomes and reduce medical costs through earlier diagnosis and treatment of cancer, should it develop
Counsel patients and family members on the underlying cause of a cancer in their family
Avoid the cost and complications of unnecessary interventions involving family members who do not test positive for the mutation
Medical Management Strategies that May Reduce Risk and Preempt Cancer
Advantages of Myriad Genetic Laboratories
We strive to be the highest quality, highest throughput clinical genetic testing laboratory in the world, offering the most accurate results possible. Our testing is based upon years of rigorous scientific research, and is designed to provide useful answers to important clinical questions. Our customer service network provides significant advantages to your practice:
Industry-leading turnaround times, with results typically reported less than 14 days after receipt of a sample*
Proprietary, automated systems to ensure specimen integrity
Streamlined reimbursement process that reduces test delays and cancellations and eliminates work for your staff
Patients know their financial obligations prior to testing, with most paying less than 10% of the cost out of pocket (excluding any unmet deductibles)
Experienced clinical support specialists available via email and phone to answer clinical questions and assist in results interpretation
*Based on current experience
For more information call Myriad Genetic Laboratories at 1-800-469-7423.
